Fresenius SE Basic EPS 2016-2024 | FSNUY

Fresenius SE annual/quarterly basic eps history and growth rate from 2016 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Fresenius SE basic eps for the quarter ending June 30, 2024 was $-0.18, a 556.41% decline year-over-year.
  • Fresenius SE basic eps for the twelve months ending June 30, 2024 was $-0.53, a 216.16% decline year-over-year.
  • Fresenius SE annual basic eps for 2023 was $-0B, a 144.17% decline from 2022.
  • Fresenius SE annual basic eps for 2022 was $0.001B, a 33.3% decline from 2021.
  • Fresenius SE annual basic eps for 2021 was $0.001B, a 10.3% increase from 2020.
Fresenius SE Annual Basic EPS
2023 $-0.28
2022 $0.64
2021 $0.96
2020 $0.87
2019 $0.95
2018 $1.08
2017 $0.92
2016 $0.81
2015 $0.69
Fresenius SE Quarterly Basic EPS
2024-06-30 $-0.18
2024-03-31 $0.13
2023-12-31 $-0.29
2023-09-30 $-0.20
2023-06-30 $0.04
2023-03-31 $0.16
2022-12-31 $0.11
2022-09-30 $0.14
2022-06-30 $0.18
2022-03-31 $0.21
2021-12-31 $0.26
2021-09-30 $0.22
2021-06-30 $0.25
2021-03-31 $0.24
2020-12-31 $0.22
2020-09-30 $0.23
2020-06-30 $0.20
2020-03-31 $0.23
2019-12-31 $0.26
2019-09-30 $0.22
2019-06-30 $0.24
2019-03-31 $0.23
2018-12-31 $0.27
2018-09-30 $0.22
2018-06-30 $0.35
2018-03-31 $0.24
2017-12-31 $0.27
2017-09-30 $0.21
2017-06-30 $0.22
2017-03-31 $0.22
2016-12-31 $0.22
2016-09-30 $0.20
2016-06-30 $0.20
2016-03-31 $0.18
2015-12-31 $0.18
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.039B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00